KBC Group NV Takes $199,000 Position in Astera Labs, Inc. (NASDAQ:ALAB)

KBC Group NV purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,504 shares of the company’s stock, valued at approximately $199,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ALAB. Geneos Wealth Management Inc. acquired a new position in shares of Astera Labs during the fourth quarter valued at approximately $36,000. ORG Wealth Partners LLC acquired a new position in Astera Labs in the 4th quarter valued at $42,000. Hollencrest Capital Management acquired a new position in Astera Labs in the 3rd quarter valued at $26,000. GAMMA Investing LLC boosted its stake in Astera Labs by 78.3% during the 4th quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock worth $68,000 after purchasing an additional 224 shares during the last quarter. Finally, Berbice Capital Management LLC purchased a new stake in shares of Astera Labs during the fourth quarter worth $86,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 11,000 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total transaction of $1,292,500.00. Following the sale, the director now directly owns 456,863 shares in the company, valued at $53,681,402.50. This represents a 2.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jitendra Mohan sold 171,064 shares of the stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $103.53, for a total transaction of $17,710,255.92. Following the sale, the chief executive officer now directly owns 628,895 shares in the company, valued at $65,109,499.35. This represents a 21.38 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,640,452 shares of company stock worth $163,096,256.

Astera Labs Stock Performance

Shares of ALAB opened at $101.73 on Wednesday. The company’s 50-day moving average price is $122.27 and its 200 day moving average price is $80.67. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $147.39.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.06. The business had revenue of $113.10 million for the quarter, compared to the consensus estimate of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. Astera Labs’s revenue for the quarter was up 47.1% compared to the same quarter last year. On average, analysts forecast that Astera Labs, Inc. will post -0.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on ALAB shares. Northland Capmk upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th. JPMorgan Chase & Co. upped their price target on Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Barclays lifted their price objective on Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a research report on Friday, January 17th. Stifel Nicolaus upped their target price on Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a report on Monday, January 6th. Finally, Craig Hallum lifted their price target on Astera Labs from $75.00 to $105.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $107.42.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.